Data as of Dec 18
| +2.32 / +2.54%|
The 5 analysts offering 12-month price forecasts for Bio-Techne Corp have a median target of 102.00, with a high estimate of 113.00 and a low estimate of 98.00. The median estimate represents a +8.90% increase from the last price of 93.66.
The current consensus among 6 polled investment analysts is to Buy stock in Bio-Techne Corp. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.